Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning - Soo brand Enoki Mushrooms recalled due to Listeria monocytogenes


Product photos are available at https://bit.ly/3BwBc9b

OTTAWA, ON, Aug. 30, 2021 /CNW/ - T-Brother Food & Trading Ltd. is recalling Soo brand Enoki Mushrooms from the marketplace due to possible Listeria monocytogenes contamination. Consumers should not consume the recalled product described below.

The following product has been sold in Alberta and British Columbia and may have been distributed in other provinces or territories.

Recalled product

Brand

Product

Size

UPC

Codes

Soo

Enoki Mushroom

200 g

6 23431 92001 5

3.2.10 21

 

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.

Background

This recall was triggered by the Canadian Food Inspection Agency's (CFIA) inspection activities. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Illnesses

There have been no reported illnesses associa

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:15
Edwards Lifesciences plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To...

at 07:15
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...

at 07:15
NeoGenomics, Inc. , a leading oncology testing services company, today announced two promotions within its senior leadership team, effective immediately. Warren Stone has been promoted to Chief Commercial Officer and will lead NeoGenomics' clinical...

at 07:15
At its recent Annual Conference, 101 Mobility, a leader in mobility and accessibility solutions, proudly introduced the Royce Barnhardt Excellence Award. This prestigious award is named in honor of Royce Barnhardt, the father of the company's...

at 07:13
Calliditas Therapeutics AB ("Calliditas"), today announced additional data analyses from the 2-year Phase 3 NeflgArd trial evaluating Nefecon (TARPEYO® (budesonide) delayed-release capsules/Kinpeygo®) in patients with IgA nephropathy (IgAN), were...

at 07:13
In a significant leap towards combating health inequities and improving community health, HDR Healthcare Network is proud to implement the HealthPrevent360 program, a comprehensive healthcare solution designed to transform the landscape of preventive...



News published on and distributed by: